ArticleJournal of molecular histology2022

Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.

Fang Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.